Advances in AI, data, and computational sciences are transforming drug discovery and development. Roche’s Research and Early Development organisations at Genentech (gRED) and Pharma (pRED) have demonstrated how these technologies accelerate R&D, leveraging data and novel computational models to drive impact. Seamless data sharing and access to models across gRED and pRED are essential to maximising these opportunities. The new Computational Sciences Center of Excellence (CoE) is a strategic, unified group whose goal is to harness this transformative power of data and Artificial Intelligence (AI) to assist our scientists in both pRED and gRED to deliver more innovative and transformative medicines for patients worldwide. We are seeking a highly motivated and collaborative Senior/Principal Machine Learning Scientist to join the Perturbation Biology group in the Department of AI for Biology & Translation (AIBT) in Genentech Research and Early Development (gRED). The successful candidate will develop the next generation of machine learning models to derive actionable insights from large-scale high-content perturbation experiments for target and drug discovery. This role requires a deep understanding of machine learning applied to sequencing-based perturbation data, a passion for innovation and inter-disciplinary research, and a commitment to improving healthcare outcomes through cutting-edge technology. We are looking for exceptional researchers with a proven ability to develop and implement research ideas. The candidate is expected to lead high profile projects in collaboration with our therapeutic area leads, and to routinely publish work in top-tier machine learning and scientific venues.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree